These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 11115498)

  • 1. Rescue of contractile parameters and myocyte hypertrophy in calsequestrin overexpressing myocardium by phospholamban ablation.
    Sato Y; Kiriazis H; Yatani A; Schmidt AG; Hahn H; Ferguson DG; Sako H; Mitarai S; Honda R; Mesnard-Rouiller L; Frank KF; Beyermann B; Wu G; Fujimori K; Dorn GW; Kranias EG
    J Biol Chem; 2001 Mar; 276(12):9392-9. PubMed ID: 11115498
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cardiac-specific overexpression of mouse cardiac calsequestrin is associated with depressed cardiovascular function and hypertrophy in transgenic mice.
    Sato Y; Ferguson DG; Sako H; Dorn GW; Kadambi VJ; Yatani A; Hoit BD; Walsh RA; Kranias EG
    J Biol Chem; 1998 Oct; 273(43):28470-7. PubMed ID: 9774476
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Functional properties of transgenic mouse hearts overexpressing both calsequestrin and the Na(+)-Ca(2+) exchanger.
    Linck B; Bokník P; Huke S; Kirchhefer U; Knapp J; Lüss H; Müller FU; Neumann J; Tanriseven Z; Vahlensieck U; Baba HA; Jones LR; Philipson KD; Schmitz W
    J Pharmacol Exp Ther; 2000 Aug; 294(2):648-57. PubMed ID: 10900244
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phospholamban ablation and compensatory responses in the mammalian heart.
    Chu G; Ferguson DG; Edes I; Kiss E; Sato Y; Kranias EG
    Ann N Y Acad Sci; 1998 Sep; 853():49-62. PubMed ID: 10603936
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Maximal inhibition of SERCA2 Ca(2+) affinity by phospholamban in transgenic hearts overexpressing a non-phosphorylatable form of phospholamban.
    Brittsan AG; Carr AN; Schmidt AG; Kranias EG
    J Biol Chem; 2000 Apr; 275(16):12129-35. PubMed ID: 10766848
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cardiac-specific overexpression of phospholamban alters calcium kinetics and resultant cardiomyocyte mechanics in transgenic mice.
    Kadambi VJ; Ponniah S; Harrer JM; Hoit BD; Dorn GW; Walsh RA; Kranias EG
    J Clin Invest; 1996 Jan; 97(2):533-9. PubMed ID: 8567978
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulation of Ca2+ signaling in transgenic mouse cardiac myocytes overexpressing calsequestrin.
    Jones LR; Suzuki YJ; Wang W; Kobayashi YM; Ramesh V; Franzini-Armstrong C; Cleemann L; Morad M
    J Clin Invest; 1998 Apr; 101(7):1385-93. PubMed ID: 9525981
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Up-regulation of sarcoplasmic reticulum Ca(2+) uptake leads to cardiac hypertrophy, contractile dysfunction and early mortality in mice deficient in CASQ2.
    Kalyanasundaram A; Lacombe VA; Belevych AE; Brunello L; Carnes CA; Janssen PM; Knollmann BC; Periasamy M; Gyørke S
    Cardiovasc Res; 2013 May; 98(2):297-306. PubMed ID: 23135969
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modulation of SR Ca2+ release by the triadin-to-calsequestrin ratio in ventricular myocytes.
    Kučerová D; Baba HA; Bokník P; Fabritz L; Heinick A; Mát'uš M; Müller FU; Neumann J; Schmitz W; Kirchhefer U
    Am J Physiol Heart Circ Physiol; 2012 May; 302(10):H2008-17. PubMed ID: 22427521
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rescue of cardiomyocyte dysfunction by phospholamban ablation does not prevent ventricular failure in genetic hypertrophy.
    Song Q; Schmidt AG; Hahn HS; Carr AN; Frank B; Pater L; Gerst M; Young K; Hoit BD; McConnell BK; Haghighi K; Seidman CE; Seidman JG; Dorn GW; Kranias EG
    J Clin Invest; 2003 Mar; 111(6):859-67. PubMed ID: 12639992
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Superinhibition of sarcoplasmic reticulum function by phospholamban induces cardiac contractile failure.
    Haghighi K; Schmidt AG; Hoit BD; Brittsan AG; Yatani A; Lester JW; Zhai J; Kimura Y; Dorn GW; MacLennan DH; Kranias EG
    J Biol Chem; 2001 Jun; 276(26):24145-52. PubMed ID: 11328820
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Monomeric phospholamban overexpression in transgenic mouse hearts.
    Chu G; Dorn GW; Luo W; Harrer JM; Kadambi VJ; Walsh RA; Kranias EG
    Circ Res; 1997 Oct; 81(4):485-92. PubMed ID: 9314829
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulation of myocardial function by histidine-rich, calcium-binding protein.
    Fan GC; Gregory KN; Zhao W; Park WJ; Kranias EG
    Am J Physiol Heart Circ Physiol; 2004 Oct; 287(4):H1705-11. PubMed ID: 15191886
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reduced myocardial sarcoplasmic reticulum Ca(2+)-ATPase protein expression in compensated primary and secondary human cardiac hypertrophy.
    Schotten U; Koenigs B; Rueppel M; Schoendube F; Boknik P; Schmitz W; Hanrath P
    J Mol Cell Cardiol; 1999 Aug; 31(8):1483-94. PubMed ID: 10423346
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cardiac hypertrophy and impaired relaxation in transgenic mice overexpressing triadin 1.
    Kirchhefer U; Neumann J; Baba HA; Begrow F; Kobayashi YM; Reinke U; Schmitz W; Jones LR
    J Biol Chem; 2001 Feb; 276(6):4142-9. PubMed ID: 11069905
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cardiac-specific overexpression of a superinhibitory pentameric phospholamban mutant enhances inhibition of cardiac function in vivo.
    Zhai J; Schmidt AG; Hoit BD; Kimura Y; MacLennan DH; Kranias EG
    J Biol Chem; 2000 Apr; 275(14):10538-44. PubMed ID: 10744747
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combined phospholamban ablation and SERCA1a overexpression result in a new hyperdynamic cardiac state.
    Zhao W; Frank KF; Chu G; Gerst MJ; Schmidt AG; Ji Y; Periasamy M; Kranias EG
    Cardiovasc Res; 2003 Jan; 57(1):71-81. PubMed ID: 12504816
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeted ablation of the phospholamban gene is associated with markedly enhanced myocardial contractility and loss of beta-agonist stimulation.
    Luo W; Grupp IL; Harrer J; Ponniah S; Grupp G; Duffy JJ; Doetschman T; Kranias EG
    Circ Res; 1994 Sep; 75(3):401-9. PubMed ID: 8062415
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sprint training normalizes Ca(2+) transients and SR function in postinfarction rat myocytes.
    Zhang LQ; Zhang XQ; Ng YC; Rothblum LI; Musch TI; Moore RL; Cheung JY
    J Appl Physiol (1985); 2000 Jul; 89(1):38-46. PubMed ID: 10904033
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Overexpression of the Na(+)-Ca2+ exchanger leads to enhanced inotropic responsiveness to Na(+)-channel agonist without sarcoplasmic reticulum protein changes in transgenic mice.
    Bäumer AT; Flesch M; Kilter H; Philipson KD; Böhm M
    Biochem Biophys Res Commun; 1998 Aug; 249(3):786-90. PubMed ID: 9731214
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.